Skip to main content
. 2012 Jan 26;106(5):854–857. doi: 10.1038/bjc.2012.10

Figure 3.

Figure 3

Sum of target lesions over time in the five patients with a TGr <0.9 who were taken off study because of progressive disease according to RECIST 1.1 and who had no new lesion during treatment.